ASO Author Reflections: Decoding the Complexities of Cytoreductive Surgery and HIPEC Procedural Billing: A Potential Blueprint for the Peritoneal Surface Malignancy Surgeon
Ann Surg Oncol. 2023 Nov 19. doi: 10.1245/s10434-023-14582-1. Online ahead of print.NO ABSTRACTPMID:37980705 | DOI:10.1245/s10434-023-14582-1 (Source: Ann Oncol)
Source: Ann Oncol - November 19, 2023 Category: Cancer & Oncology Authors: Andres A Abreu Sam C Wang Giorgios Karagkounis Patricio M Polanco Source Type: research
ACR Payer Advocacy on Underwater Biosimilars
The ACR is engaging with payers regarding formulary requirements that would leave practices underwater when treating patients with rheumatic diseases. (Source: The Rheumatologist)
Source: The Rheumatologist - November 17, 2023 Category: Rheumatology Authors: From the College Tags: Billing/Coding Legislation & Advocacy infliximab biosimilar Reimbursement Source Type: research
ACR Advocates with Payers Against Insufficient Reimbursement for Biosimilars
The ACR is engaging with payers regarding formulary requirements that would leave practices underwater when treating patients with rheumatic diseases. (Source: The Rheumatologist)
Source: The Rheumatologist - November 17, 2023 Category: Rheumatology Authors: From the College Tags: Billing/Coding Legislation & Advocacy infliximab biosimilar Reimbursement Source Type: research
AI Will Not Reduce Health Care ’s Administrative Burden
This Viewpoint considers AI ’s limits in solving the medical billing quagmire and argues that standardizing health insurance claim forms and simplifying billing must occur before AI can shoulder the load. (Source: JAMA - Journal of the American Medical Association)
Source: JAMA - Journal of the American Medical Association - November 16, 2023 Category: General Medicine Source Type: research
NTS-105 decreased cell death and preserved long-term potentiation in an in vitro model of moderate traumatic brain injury
Exp Neurol. 2023 Nov 8:114608. doi: 10.1016/j.expneurol.2023.114608. Online ahead of print.ABSTRACTTraumatic brain injury (TBI) is a major cause of hospitalization and death. To mitigate these human costs, the search for effective drugs to treat TBI continues. In the current study, we evaluated the efficacy of the novel neurosteroid, NTS-105, to reduce post-traumatic pathobiology in an in vitro model of moderate TBI that utilizes an organotypic hippocampal slice culture. NTS-105 inhibited activation of the androgen receptor and the mineralocorticoid receptor, partially activated the progesterone B receptor and was not acti...
Source: Experimental Neurology - November 10, 2023 Category: Neurology Authors: Mary Kate R Dwyer Nicolas Amelinez-Robles Isabella Polsfuss Keondre Herbert Carolyn Kim Nevin Varghese Tom J Parry Benjamin Buller Todd A Verdoorn Clare B Billing Barclay Morrison Source Type: research
NTS-105 decreased cell death and preserved long-term potentiation in an in vitro model of moderate traumatic brain injury
Exp Neurol. 2023 Nov 9;371:114608. doi: 10.1016/j.expneurol.2023.114608. Online ahead of print.ABSTRACTTraumatic brain injury (TBI) is a major cause of hospitalization and death. To mitigate these human costs, the search for effective drugs to treat TBI continues. In the current study, we evaluated the efficacy of the novel neurosteroid, NTS-105, to reduce post-traumatic pathobiology in an in vitro model of moderate TBI that utilizes an organotypic hippocampal slice culture. NTS-105 inhibited activation of the androgen receptor and the mineralocorticoid receptor, partially activated the progesterone B receptor and was not ...
Source: Experimental Neurology - November 10, 2023 Category: Neurology Authors: Mary Kate R Dwyer Nicolas Amelinez-Robles Isabella Polsfuss Keondre Herbert Carolyn Kim Nevin Varghese Tom J Parry Benjamin Buller Todd A Verdoorn Clare B Billing Barclay Morrison Source Type: research
NTS-105 decreased cell death and preserved long-term potentiation in an in vitro model of moderate traumatic brain injury
Exp Neurol. 2023 Nov 9;371:114608. doi: 10.1016/j.expneurol.2023.114608. Online ahead of print.ABSTRACTTraumatic brain injury (TBI) is a major cause of hospitalization and death. To mitigate these human costs, the search for effective drugs to treat TBI continues. In the current study, we evaluated the efficacy of the novel neurosteroid, NTS-105, to reduce post-traumatic pathobiology in an in vitro model of moderate TBI that utilizes an organotypic hippocampal slice culture. NTS-105 inhibited activation of the androgen receptor and the mineralocorticoid receptor, partially activated the progesterone B receptor and was not ...
Source: Experimental Neurology - November 10, 2023 Category: Neurology Authors: Mary Kate R Dwyer Nicolas Amelinez-Robles Isabella Polsfuss Keondre Herbert Carolyn Kim Nevin Varghese Tom J Parry Benjamin Buller Todd A Verdoorn Clare B Billing Barclay Morrison Source Type: research
NTS-105 decreased cell death and preserved long-term potentiation in an in vitro model of moderate traumatic brain injury
Exp Neurol. 2023 Nov 9;371:114608. doi: 10.1016/j.expneurol.2023.114608. Online ahead of print.ABSTRACTTraumatic brain injury (TBI) is a major cause of hospitalization and death. To mitigate these human costs, the search for effective drugs to treat TBI continues. In the current study, we evaluated the efficacy of the novel neurosteroid, NTS-105, to reduce post-traumatic pathobiology in an in vitro model of moderate TBI that utilizes an organotypic hippocampal slice culture. NTS-105 inhibited activation of the androgen receptor and the mineralocorticoid receptor, partially activated the progesterone B receptor and was not ...
Source: Experimental Neurology - November 10, 2023 Category: Neurology Authors: Mary Kate R Dwyer Nicolas Amelinez-Robles Isabella Polsfuss Keondre Herbert Carolyn Kim Nevin Varghese Tom J Parry Benjamin Buller Todd A Verdoorn Clare B Billing Barclay Morrison Source Type: research
NTS-105 decreased cell death and preserved long-term potentiation in an in vitro model of moderate traumatic brain injury
Exp Neurol. 2023 Nov 9;371:114608. doi: 10.1016/j.expneurol.2023.114608. Online ahead of print.ABSTRACTTraumatic brain injury (TBI) is a major cause of hospitalization and death. To mitigate these human costs, the search for effective drugs to treat TBI continues. In the current study, we evaluated the efficacy of the novel neurosteroid, NTS-105, to reduce post-traumatic pathobiology in an in vitro model of moderate TBI that utilizes an organotypic hippocampal slice culture. NTS-105 inhibited activation of the androgen receptor and the mineralocorticoid receptor, partially activated the progesterone B receptor and was not ...
Source: Experimental Neurology - November 10, 2023 Category: Neurology Authors: Mary Kate R Dwyer Nicolas Amelinez-Robles Isabella Polsfuss Keondre Herbert Carolyn Kim Nevin Varghese Tom J Parry Benjamin Buller Todd A Verdoorn Clare B Billing Barclay Morrison Source Type: research
NTS-105 decreased cell death and preserved long-term potentiation in an in vitro model of moderate traumatic brain injury
Exp Neurol. 2023 Nov 9;371:114608. doi: 10.1016/j.expneurol.2023.114608. Online ahead of print.ABSTRACTTraumatic brain injury (TBI) is a major cause of hospitalization and death. To mitigate these human costs, the search for effective drugs to treat TBI continues. In the current study, we evaluated the efficacy of the novel neurosteroid, NTS-105, to reduce post-traumatic pathobiology in an in vitro model of moderate TBI that utilizes an organotypic hippocampal slice culture. NTS-105 inhibited activation of the androgen receptor and the mineralocorticoid receptor, partially activated the progesterone B receptor and was not ...
Source: Experimental Neurology - November 10, 2023 Category: Neurology Authors: Mary Kate R Dwyer Nicolas Amelinez-Robles Isabella Polsfuss Keondre Herbert Carolyn Kim Nevin Varghese Tom J Parry Benjamin Buller Todd A Verdoorn Clare B Billing Barclay Morrison Source Type: research
NTS-105 decreased cell death and preserved long-term potentiation in an in vitro model of moderate traumatic brain injury
Exp Neurol. 2023 Nov 9;371:114608. doi: 10.1016/j.expneurol.2023.114608. Online ahead of print.ABSTRACTTraumatic brain injury (TBI) is a major cause of hospitalization and death. To mitigate these human costs, the search for effective drugs to treat TBI continues. In the current study, we evaluated the efficacy of the novel neurosteroid, NTS-105, to reduce post-traumatic pathobiology in an in vitro model of moderate TBI that utilizes an organotypic hippocampal slice culture. NTS-105 inhibited activation of the androgen receptor and the mineralocorticoid receptor, partially activated the progesterone B receptor and was not ...
Source: Experimental Neurology - November 10, 2023 Category: Neurology Authors: Mary Kate R Dwyer Nicolas Amelinez-Robles Isabella Polsfuss Keondre Herbert Carolyn Kim Nevin Varghese Tom J Parry Benjamin Buller Todd A Verdoorn Clare B Billing Barclay Morrison Source Type: research
NTS-105 decreased cell death and preserved long-term potentiation in an in vitro model of moderate traumatic brain injury
Exp Neurol. 2023 Nov 9;371:114608. doi: 10.1016/j.expneurol.2023.114608. Online ahead of print.ABSTRACTTraumatic brain injury (TBI) is a major cause of hospitalization and death. To mitigate these human costs, the search for effective drugs to treat TBI continues. In the current study, we evaluated the efficacy of the novel neurosteroid, NTS-105, to reduce post-traumatic pathobiology in an in vitro model of moderate TBI that utilizes an organotypic hippocampal slice culture. NTS-105 inhibited activation of the androgen receptor and the mineralocorticoid receptor, partially activated the progesterone B receptor and was not ...
Source: Experimental Neurology - November 10, 2023 Category: Neurology Authors: Mary Kate R Dwyer Nicolas Amelinez-Robles Isabella Polsfuss Keondre Herbert Carolyn Kim Nevin Varghese Tom J Parry Benjamin Buller Todd A Verdoorn Clare B Billing Barclay Morrison Source Type: research
NTS-105 decreased cell death and preserved long-term potentiation in an in vitro model of moderate traumatic brain injury
Exp Neurol. 2023 Nov 9;371:114608. doi: 10.1016/j.expneurol.2023.114608. Online ahead of print.ABSTRACTTraumatic brain injury (TBI) is a major cause of hospitalization and death. To mitigate these human costs, the search for effective drugs to treat TBI continues. In the current study, we evaluated the efficacy of the novel neurosteroid, NTS-105, to reduce post-traumatic pathobiology in an in vitro model of moderate TBI that utilizes an organotypic hippocampal slice culture. NTS-105 inhibited activation of the androgen receptor and the mineralocorticoid receptor, partially activated the progesterone B receptor and was not ...
Source: Experimental Neurology - November 10, 2023 Category: Neurology Authors: Mary Kate R Dwyer Nicolas Amelinez-Robles Isabella Polsfuss Keondre Herbert Carolyn Kim Nevin Varghese Tom J Parry Benjamin Buller Todd A Verdoorn Clare B Billing Barclay Morrison Source Type: research
American Association of Endocrine Surgeons recorder ’s note (January 2024 issue)
This issue of Surgery, like past years, includes the proceedings of our annual American Association of Endocrine Surgeons (AAES) meeting from April 2023 in Birmingham, Alabama. It features the excellent scientific work of our members with the transcribed discussions of each presented paper, which are in many ways even more illustrative than the work itself. This issue also contains the ‘AAES Position Statement on Selected Endocrine Surgery Billing Codes and Procedures: Addressing Gaps in the Current Coding Paradigm’ and an expanded section on innovation and technology. (Source: Surgery)
Source: Surgery - November 8, 2023 Category: Surgery Authors: Kepal N. Patel Source Type: research
Method validation and environmental monitoring of triethanolamine ester quaternary ammonium compounds
In this study water and sediment samples, collected from the River Nene (Northamptonshire) at several sites in the vicinity of the Great Billing sewage treatment plant (STP), were analysed for triethanolamine quaternary compounds (TEAQ, ester quats). A method was developed using liquid chromatography tandem mass spectrometry (LC/MS/MS) with a electrospray ionisation source (ESI). Ten components were determined using a characterised commercial sample of Tallow TEAQ as a standard. To our knowledge this is the first time environmental concentrations of a wide spectrum of individual homologues of TEAQ have been reliably quanti...
Source: Chemosphere - November 1, 2023 Category: Chemistry Authors: Chris Sparham Moira Ledbetter Richard Cubberley Dave Gore David Sheffield Alex Teixeira Geoff Hodges Source Type: research
